Puma Biotechnology Inc reports results for the quarter ended in March - Earnings Summary

Puma Biotechnology

05/05/2022 22:42

* Puma Biotechnology Inc  PBYI.OQ  reported a quarterly
adjusted
loss of 8 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 17 cents per share.
    * Revenue fell 53.4% to $45.70 million from a year ago; 
analysts
expected $45.07 million. 
    * Puma Biotechnology Inc's reported EPS for the quarter was
a loss
of 8 cents​.
    * The mean earnings estimate of analysts had fallen by
about 551.7% in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Puma Biotechnology Inc shares had fallen by 14.6% this
quarter and lost 19.1% so far this year.
    * The company reported a quarterly loss of $3.4 million.
    * Wall Street's median 12-month price target for Puma
Biotechnology Inc is $5.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 3 "sell" or "strong sell." 

This summary was machine generated May 5 at 09:42 p.m.  ​All
figures in US dollars unless otherwise stated